ICAD 2026: International Conference on Autoimmune Disorders

ICAD 2026: International Conference on Autoimmune Disorders focuses on autoimmune disorders, addressing their mechanisms, diagnosis, epidemiology, and clinical and translational immunology across multiple disease systems.

Key Topics

• Mechanism and Etiology
• Epidemiology and Prevention
• Clinical Rheumatology
• Diagnosis and Therapy
• Gastrointestinal Autoimmunity
• Pediatric Rheumatology
• Alopecia Areata
• Thyroid Autoimmunity/Graves` Disease
• Antiphospholipid Syndrome
• Ankylosing Spondylitis (AS)
• Celiac Disease
• Autoimmune Hepatitis
• Gout/Pseudogout
• Fibromyalgia
• Mixed Connective Tissue Disease (MCTD)
• Juvenile Idiopathic Arthritis (JIA)
• Narcolepsy
• Myasthenia Gravis
• Polymyalgia Rheumatica
• Osteoarthritis
• Psoriasis/Psoriatic Arthritis
• Polymyositis and Dermatomyositis
• Rheumatoid arthritis (RA)
• Relapsing polychondritis
• Sarcoidosis
• Rheumatic Fever
• Soft Tissue Rheumatism
• Septic Arthritis
• Systemic Lupus Erythematosus (SLE)
• Spondyloarthritis
• Vasculitis / Urticarial Vasculitis
• Systemic Sclerosis / Multiple Sclerosis
• IVIG and Natural Autoantibodies
• Innate Autoimmunity and Natural Antibodies
• Genetics and Epigenetics in Autoimmunity
• Protective Antibodies
• Heat Shock Protein in Autoimmunity
• Complement in Autoimmunity
• Toll-like Receptors and Autoimmunity
• IL17, Th17 and Cytokines in Autoimmunity
• Infection and Autoimmunity
• Immunodeficiency and Autoimmunity
• Hematological Disease and Autoimmunity
• Pregnancy and Autoimmunity
• Liver/Skin and Autoimmunity
• Central Nervous System and Autoimmunity
• Biomarkers
• Experimental Models
• Translational Immunology